These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 4279346)

  • 21. Development of a strain of spontaneously hypertensive rats.
    OKAMOTO K; AOKI K
    Jpn Circ J; 1963 Mar; 27():282-93. PubMed ID: 13939773
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of immunosympathectomy on development of high blood pressure in genetically hypertensive rats.
    Clark DW
    Circ Res; 1971 Mar; 28(3):330-6. PubMed ID: 5545899
    [No Abstract]   [Full Text] [Related]  

  • 23. Permanent depletion of peripheral norepinephrine in rats treated at birth with 6-hydroxydopamine.
    Jaim-Etcheverry G; Zieher LM
    Eur J Pharmacol; 1971 Jan; 13(2):272-6. PubMed ID: 5544082
    [No Abstract]   [Full Text] [Related]  

  • 24. An assessment of the role of the sympathetic nervous system in experimental hypertension using normal and immunosympathectomized rats.
    Ayitey-Smith E; Varma DR
    Br J Pharmacol; 1970 Oct; 40(2):175-85. PubMed ID: 5492890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the adrenal medulla contribute to the maintenance of experimental hypertension?
    Finch L; Leach GF
    Eur J Pharmacol; 1970; 11(3):388-91. PubMed ID: 5477314
    [No Abstract]   [Full Text] [Related]  

  • 26. Background of increased flow resistance and vascular reactivity in spontaneously hypertensive rats.
    Folkow B; Hallbäck M; Lundgren Y; Weiss L
    Acta Physiol Scand; 1970 Sep; 80(1):93-106. PubMed ID: 5475335
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies with renal hypertensive rats.
    Vapaatalo HI; Lahovaara S; Hackman R
    Ann Med Exp Biol Fenn; 1970; 48(1):28-32. PubMed ID: 5427230
    [No Abstract]   [Full Text] [Related]  

  • 28. The contribution of the sympathetic nervous system to the development and maintenance of experimental hypertension in the rat.
    Finch L; Leach GD
    Br J Pharmacol; 1970 Jun; 39(2):317-24. PubMed ID: 5425276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical sympathectomy of the cat with 6-hydroxydopamine.
    Haeusler G; Haefely W; Thoenen H
    J Pharmacol Exp Ther; 1969 Nov; 170(1):50-61. PubMed ID: 5351006
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of intracisternal 6-hydroxydopamine on the development of neurogenic hypertension in the rabbit.
    Chalmers JP; Reid JL
    J Physiol; 1971 Dec; 219(2):20P-21P. PubMed ID: 5158378
    [No Abstract]   [Full Text] [Related]  

  • 31. Early pre- and postjunctional effects of 6-hydroxydopamine.
    Haeusler G
    J Pharmacol Exp Ther; 1971 Jul; 178(1):49-62. PubMed ID: 5087404
    [No Abstract]   [Full Text] [Related]  

  • 32. Central adrenergic neurones and the initiation and development of experimental hypertension.
    Haeusler G; Finch L; Thoenen H
    Experientia; 1972 Oct; 28(10):1200-3. PubMed ID: 5087039
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of tissue norepinephrine depletion by 6-hydroxydopamine on blood pressure in spontaneously hypertensive rats.
    Yamori Y; Yamabe H; De Jong W; Lovenberg W; Sjoerdsma A
    Eur J Pharmacol; 1972 Jan; 17(1):135-40. PubMed ID: 5016572
    [No Abstract]   [Full Text] [Related]  

  • 34. Rapid recovery of vascular adrenergic nerves in the rat after chemical sympathectomy with 6-hydroxydopamine.
    Finch L; Haeusler G; Kuhn H; Thoenen H
    Br J Pharmacol; 1973 May; 48(1):59-72. PubMed ID: 4724194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-lasting peripheral and central effects of 6-hydroxydopamine in rats.
    Clark DW; Laverty R; Phelan EL
    Br J Pharmacol; 1972 Feb; 44(2):233-43. PubMed ID: 4677508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular effects of 6-hydroxydopamine injected into a lateral brain ventricle of the rat.
    Haeusler G; Gerold M; Thoenen H
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 274(3):211-28. PubMed ID: 4403647
    [No Abstract]   [Full Text] [Related]  

  • 37. Resistance of noradrenaline in blood vessels to depletion by 6-hydroxydopamine or immunosympathectomy.
    Berkowitz BA; Spector S; Tarver JH
    Br J Pharmacol; 1972 Jan; 44(1):10-6. PubMed ID: 4401306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the effects of 6-hydroxydopamine immunosympathectomy and reserpine on the cardiovascular reactivity in the rat.
    Finch L; Leach GD
    J Pharm Pharmacol; 1970 May; 22(5):354-60. PubMed ID: 4392993
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine.
    Thoenen H; Tranzer JP
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 261(3):271-88. PubMed ID: 4387076
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the significance of the noradrenaline content of fatty tissue for the mobilization of unesterified fatty acids].
    Stock K; Westermann E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1965 Sep; 251(5):465-87. PubMed ID: 4379204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.